Welcome to visitJiangsu High-wit Medical Ltd.Enterprise official website
21
2020
-
05
The country's first peripheral drug-eluting stent has been approved for market launch.
On April 9, the National Medical Products Administration announced the approval of the registration of the priority product "Drug-Eluting Peripheral Vascular Stent" produced by Cook Ireland Limited.
On April 9, the National Medical Products Administration announced the approval of the registration of the priority product "Drug-Eluting Peripheral Vascular Stent" produced by Cook Ireland Limited.
The product consists of a pre-loaded stent and delivery system, including syringe accessories. It is suitable for treating symptomatic lesions in the above-knee femoral-popliteal artery with a reference vessel diameter of 4-9mm.
This product is the first approved drug-eluting stent for peripheral use in our country, capable of supporting residual stenosis of lesions and reducing elastic recoil after balloon dilation; the paclitaxel coating can inhibit the proliferation of vascular smooth muscle cells, with the expectation of reducing the occurrence of restenosis. This product can optimize the current treatment options for peripheral vascular diseases, better meeting clinical needs.
More news
Address: Building B2, No.9 Kechuang Avenue, Jiangbei New District, Nanjing
High-wit Micro Mall
High-wit official website